Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disparities in Stroke Patient-Reported Outcomes Measurement Between Healthcare Systems in Brazil.
Martins SCO, Borelli WV, Secchi TL, Mantovani GP, Pille A, Mora Cuervo DL, Carbonera LA, de Souza AC, Martins MCO, Brondani R, de Almeida AG, Dal Pizzol A, Dos Santos FP, Alves AC, Meier NS, Andrade GPB, Maciel PA, Weber A, Machado GD, Parrini M, Nasi LA. Martins SCO, et al. Among authors: martins mco. Front Neurol. 2022 May 6;13:857094. doi: 10.3389/fneur.2022.857094. eCollection 2022. Front Neurol. 2022. PMID: 35599734 Free PMC article.
Validation of a Smartphone Application in the Evaluation and Treatment of Acute Stroke in a Comprehensive Stroke Center.
Martins SCO, Weiss G, Almeida AG, Brondani R, Carbonera LA, de Souza AC, Martins MCO, Nasi G, Nasi LA, Batista C, Sousa FB, Rockenbach MABC, Gonçalves FM, Vedolin LM, Nogueira RG. Martins SCO, et al. Among authors: martins mco. Stroke. 2020 Jan;51(1):240-246. doi: 10.1161/STROKEAHA.119.026727. Epub 2019 Dec 18. Stroke. 2020. PMID: 31847753 Clinical Trial.
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, Li Q, Billot L, Delcourt C, Bath PM, Broderick JP, Demchuk AM, Donnan GA, Durham AC, Lavados PM, Lee TH, Levi C, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Silva F, Song L, Thang NH, Wardlaw JM, Wang JG, Wang X, Woodward M, Chalmers J, Robinson TG; ENCHANTED Investigators and Coordinators. Anderson CS, et al. Lancet. 2019 Mar 2;393(10174):877-888. doi: 10.1016/S0140-6736(19)30038-8. Epub 2019 Feb 7. Lancet. 2019. PMID: 30739745 Clinical Trial.